{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Eosinophilic asthma and the role of monoclonal antibodies

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the diagnostic process for patients with eosinophilic asthma (EA).
  2. Apply knowledge of monoclonal antibodies (mAbs) in the treatment of patients with EA.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 1.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours







Test Code: NP0421A
Published: April 2021
Expires: 3/3/2023
Required Passing Score: 7/10 (70%)
Authors: Lynda Jarrell, DNP, APRN, FNP-BC, CNE